Back
Abercrombie & Fitch Vs. PTC Therapeutics Industry Stock Comparison
Buy
79
ANF
Abercrombie & Fitch
Last Price:
183.38
Seasonality Move:
-2.24%
Sell
40
PTCT
PTC Therapeutics
Last Price:
30.41
Seasonality Move:
8.11%
Buy
79
Abercrombie & Fitch (ANF)
is a Buy
Is Abercrombie & Fitch a Buy, Sell or Hold?
- The current Abercrombie & Fitch [ANF] share price is $184.59. The Score for ANF is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- ANF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $31.17. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANF Stock Price Chart
What is Abercrombie & Fitch's stock price today?
-
The Abercrombie & Fitch share price today is $184.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANF is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $31.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
ANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.13 | Buy |
| Relative Strength Index (14 RSI): | 63.06 | Buy |
| Chaikin Money Flow: | 1166143 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (166.93 - 187.09) | Buy |
| Bollinger Bands (100): | (113.2 - 162.36) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.53 | Sell |
| Relative Strength Index (14 RSI): | 37.27 | Sell |
| Chaikin Money Flow: | 51415 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34 - 37.72) | Sell |
| Bollinger Bands (100): | (26.7 - 35.2) | Buy |
ANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 175.2 | Buy |
| 20-day SMA: | 179.09 | Buy |
| 50-day SMA: | 153.02 | Buy |
| 200-day SMA: | 106.92 | Buy |
| 8-day EMA: | 177.89 | Buy |
| 20-day EMA: | 174.5 | Buy |
| 50-day EMA: | 158.92 | Buy |
| 200-day EMA: | 114.18 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.02 | Sell |
| 20-day SMA: | 35.78 | Sell |
| 50-day SMA: | 33.9 | Sell |
| 200-day SMA: | 27.61 | Buy |
| 8-day EMA: | 33.59 | Sell |
| 20-day EMA: | 34.77 | Sell |
| 50-day EMA: | 33.84 | Sell |
| 200-day EMA: | 31.82 | Sell |
Abercrombie & Fitch Earnings Growth & ANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.01 per share, an increase next quarter of $0.82 per share, an increase this year of $5.85 per share, and an increase next year of $3.37 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
Abercrombie & Fitch Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||